USANA Health Sciences Balance Sheet Health
Financial Health criteria checks 6/6
USANA Health Sciences has a total shareholder equity of $581.6M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $726.6M and $145.0M respectively. USANA Health Sciences's EBIT is $41.8M making its interest coverage ratio -11. It has cash and short-term investments of $145.3M.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | -11x |
| Cash | US$145.35m |
| Equity | US$581.55m |
| Total liabilities | US$145.04m |
| Total assets | US$726.59m |
Recent financial health updates
No updates
Recent updates
USANA Health Sciences, Inc. (NYSE:USNA) Looks Inexpensive After Falling 31% But Perhaps Not Attractive Enough
Oct 16
USANA Q3 2025 Preview: Short-Term Challenges Amid Strategic Transition
Oct 13Returns On Capital At USANA Health Sciences (NYSE:USNA) Paint A Concerning Picture
Oct 11USANA Health Sciences, Inc. (NYSE:USNA) Looks Inexpensive But Perhaps Not Attractive Enough
Jul 18Shareholders May Be Wary Of Increasing USANA Health Sciences, Inc.'s (NYSE:USNA) CEO Compensation Package
May 12The Market Doesn't Like What It Sees From USANA Health Sciences, Inc.'s (NYSE:USNA) Earnings Yet As Shares Tumble 25%
Apr 08There Are Reasons To Feel Uneasy About USANA Health Sciences' (NYSE:USNA) Returns On Capital
Apr 04Should You Think About Buying USANA Health Sciences, Inc. (NYSE:USNA) Now?
Dec 09USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital
Sep 26
India Expansion And Decisive Acquisitions Promise Growth Amid Analyst Concerns Over Shrinking Margins
Expansion into India and strategic acquisitions offer significant growth opportunities for USANA, potentially boosting revenue and diversifying its market presence.Is There Now An Opportunity In USANA Health Sciences, Inc. (NYSE:USNA)?
Sep 08USANA Health Sciences, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Jul 26There Is A Reason USANA Health Sciences, Inc.'s (NYSE:USNA) Price Is Undemanding
Jul 17USANA Health Sciences (NYSE:USNA) Might Be Having Difficulty Using Its Capital Effectively
May 29USANA Health Sciences, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
May 03Is Now The Time To Look At Buying USANA Health Sciences, Inc. (NYSE:USNA)?
May 01USANA Health Sciences, Inc.'s (NYSE:USNA) Prospects Need A Boost To Lift Shares
Apr 04USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital
Feb 08Is It Too Late To Consider Buying USANA Health Sciences, Inc. (NYSE:USNA)?
Jan 06USANA: New Digital Tools And Solid Balance Sheet Imply Undervaluation
Oct 23Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 22%?
Sep 09Here's What's Concerning About USANA Health Sciences' (NYSE:USNA) Returns On Capital
Jul 27Financial Position Analysis
Short Term Liabilities: USNA's short term assets ($264.1M) exceed its short term liabilities ($118.7M).
Long Term Liabilities: USNA's short term assets ($264.1M) exceed its long term liabilities ($26.4M).
Debt to Equity History and Analysis
Debt Level: USNA is debt free.
Reducing Debt: USNA currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Debt Coverage: USNA has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: USNA has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/02 01:10 |
| End of Day Share Price | 2025/10/31 00:00 |
| Earnings | 2025/09/27 |
| Annual Earnings | 2024/12/28 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
USANA Health Sciences, Inc. is covered by 7 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Scott Van Winkle | Canaccord Genuity |
| John San Marco | Janney Montgomery Scott LLC |
| Stephanie Schiller Wissink | Jefferies LLC |